FY2026 Earnings Estimate for ReWalk Robotics Ltd. (NASDAQ:LFWD) Issued By HC Wainwright

May 19, 2024

27 2 minutes read

Untitled design6 — 1712470140 rewalk robotics ltd logo 1200x675.png

ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) – Analysts at HC Wainwright raised their FY2026 EPS estimates for shares of ReWalk Robotics in a research note issued to investors on Thursday, May 16th. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn $0.47 per share for the year, up from their prior forecast of $0.35. HC Wainwright has a “Buy” rating and a $13.00 price objective on the stock. The consensus estimate for ReWalk Robotics’ current full-year earnings is ($1.75) per share.

ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported ($0.35) EPS for the quarter, beating analysts’ consensus estimates of ($0.91) by $0.56. ReWalk Robotics had a negative return on equity of 33.41% and a negative net margin of 134.52%. The firm had revenue of $6.88 million during the quarter, compared to the consensus estimate of $7.20 million.

ReWalk Robotics Price Performance

LFWD stock opened at $5.06 on Friday. The stock’s 50 day moving average is $5.00. The firm has a market capitalization of $43.52 million, a P/E ratio of -1.63 and a beta of 2.06. ReWalk Robotics has a twelve month low of $3.90 and a twelve month high of $9.10.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ReWalk Robotics stock. Kent Lake Capital LLC bought a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 157,361 shares of the company’s stock, valued at approximately $823,000. Kent Lake Capital LLC owned approximately 1.85% of ReWalk Robotics as of its most recent filing with the SEC. 26.76% of the stock is owned by institutional investors.

ReWalk Robotics Company Profile

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.